Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Coadministration of AYUSH 64 as an adjunct to Standard of Care in mild and moderate COVID-19: A randomised, controlled, multicentric clinical trial

Arvind Chopra, Girish Tillu, Kuldeep Chuadhary, Govind Reddy, Alok Srivastava, Muffazal Lakdawala, Dilip Gode, Himanshu Reddy, Sanjay Tamboli, Manjit Saluja, Sanjeev Sarmukkaddam, Manohar Gundeti, Ashwinikumar Raut, BCS Rao, Babita Yadav, Narayanam Srikanth, Bhushan Patwardhan
doi: https://doi.org/10.1101/2021.06.12.21258345
Arvind Chopra
1Centre for Rheumatic Diseases, Pune, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: arvindchopra60@hotmail.com
Girish Tillu
2Interdisciplinary School of Health Sciences, Savitribai Phule Pune University, Pune, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kuldeep Chuadhary
3Central Ayurveda Research Institute, Mumbai, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Govind Reddy
4Regional Ayurveda Research Institute, Nagpur, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alok Srivastava
5Regional Ayurveda Research Institute, Lucknow, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Muffazal Lakdawala
6H.N. Reliance Foundation Hospital and Research Centre, Mumbai, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dilip Gode
7Datta Meghe Institute of Medical Sciences, Nagpur, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Himanshu Reddy
8King George’s Medical University, Lucknow, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sanjay Tamboli
9Target Institute of Medical Education & Research, Mumbai, India, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manjit Saluja
1Centre for Rheumatic Diseases, Pune, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sanjeev Sarmukkaddam
1Centre for Rheumatic Diseases, Pune, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manohar Gundeti
3Central Ayurveda Research Institute, Mumbai, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ashwinikumar Raut
10Medical Research Centre, Kasturba Health Society, Mumbai
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
BCS Rao
11Central Council for Research in Ayurvedic Sciences, New Delhi, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Babita Yadav
11Central Council for Research in Ayurvedic Sciences, New Delhi, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Narayanam Srikanth
11Central Council for Research in Ayurvedic Sciences, New Delhi, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bhushan Patwardhan
2Interdisciplinary School of Health Sciences, Savitribai Phule Pune University, Pune, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Objectives To compare the co-administration of an Ayurvedic drug AYUSH 64 as an adjunct to standard of care (SOC) and SOC for efficacy and safety in the management of COVID-19.

Design Multicentre, parallel efficacy, randomized, controlled, open label, assessor blind, exploratory trial with a convenience sample. Patients followed to complete 12 weeks of study duration.

Setting COVID-19 dedicated non-intensive care wards at 1 government hospital, 1 medical college teaching hospital and 1 medical university teaching hospital

Participants 140 consenting, eligible, hospitalized adult patients suffering from mild and moderate symptomatic COVID-19 and confirmed by a diagnostic (SARS-CoV-2) RT-PCR assay on nasal and throat swab were randomized to SOC or SOC plus AYUSH 64. To be withdrawn if disease becomes severe.

Interventions Two tablets of AYUSH 64, 500 mg each, twice daily after meals, and continued till study completion. SOC (symptomatic and supportive) as per national guidelines of India for mild and moderate disease.

Main outcome measures Time period to clinical recovery (CR) from randomization baseline and proportion with CR within 28 days time frame; CR defined in the protocol

Results 140 patients randomized (70 in each arm); 138 patients with CR qualified for analysis. Both groups were matched at baseline. The mean time to CR from randomization was significantly superior in AYUSH 64 group (95% CI -3.03 to 0.59 days); a higher proportion (69.7%) in the first week (p=0.046, Chi-square). No significant differences observed for COVID-19 related blood assays (such as D-Dimer). AYUSH 64 arm showed significant (p<0.05) superior persistent improvement in general health, quality of life, fatigue, anxiety, stress, sleep and other psychosocial metrics. 1 patient on SOC required critical care. 48 adverse events (AE) reported in each group. Barring three SAE (in SOC), AE were mild and none were drug related. 22 participants (8 on AYUSH) were withdrawn. No deaths were reported.

Conclusions AYUSH 64 hastened recovery, reduced hospitalization and improved overall health in mild and moderate COVID-19 when co-administered with SOC under medical supervision. It was safe and well tolerated. Further studies are warranted.

Trial registration The Clinical Trials Registry India Number CTRI/2020/06/025557

Funding CCRAS, Ministry of AYUSH, Government of India

Competing Interest Statement

The authors Kuldeep Chaudhary, Alok Srivastava, Govind Reddy, Manohar Gundeti, BCS Rao, Babita Yadav, Narayanam Srikanth work in Central Council for Research in Ayurvedic Sciences (CCRAS), Ministry of AYUSH (MoA), Government of India (GOI), New Delhi. Ashwinikumar Raut was a consultant for the study. Sanjay Tamoli was involved as a CRO. AYUSH-64 is a proprietary formulation of CCRAS.

Clinical Trial

CTRI/2020/06/025557

Funding Statement

This study was funded by Central Council for Research in Ayurvedic Sciences, Ministry of Ayush, Government of India.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Institutional Ethics Committee, Datta Meghe Institute of Medical Sciences, Nagpur, India Institutional Ethics Committee, King George Medical University, Lucknow, India Institutional Ethics Committee, R R A Podar Central Ayurveda Research Institute for Cancer, Mumbai, India

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Funding Statement: This study was funded by Central Council for Research in Ayurvedic Sciences, Ministry of Ayush, Government of India.

  • Competing interests: None of the authors have any financial conflict of interest regarding this study. The authors Kuldeep Chuadhary, Alok Srivastava, Govind Reddy, Manohar Gundeti, BCS Rao, Babita Yadav, Narayanam Srikanth work in Central Council for Research in Ayurvedic Sciences (CCRAS), Ministry of AYUSH (MoA), Government of India (GOI), New Delhi. Dr Ashwinikumar Raut was a consultant for the study. Dr Sanjay Tamoli was involved as a CRO. AYUSH-64 is a proprietary formulation of CCRAS.

  • Contact Address: Arvind Chopra, MD, Director and Chief Rheumatologist, Centre for Rheumatic Diseases, Pune, India 411001, Telephone: +91 20 26345624, (M) 9822039297, Email: crdp5624{at}gmail.com

Data Availability

Not applicable

http://ctri.nic.in/Clinicaltrials/showallp.php?mid1=43812&EncHid=&userName=025557

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted June 17, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Coadministration of AYUSH 64 as an adjunct to Standard of Care in mild and moderate COVID-19: A randomised, controlled, multicentric clinical trial
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Coadministration of AYUSH 64 as an adjunct to Standard of Care in mild and moderate COVID-19: A randomised, controlled, multicentric clinical trial
Arvind Chopra, Girish Tillu, Kuldeep Chuadhary, Govind Reddy, Alok Srivastava, Muffazal Lakdawala, Dilip Gode, Himanshu Reddy, Sanjay Tamboli, Manjit Saluja, Sanjeev Sarmukkaddam, Manohar Gundeti, Ashwinikumar Raut, BCS Rao, Babita Yadav, Narayanam Srikanth, Bhushan Patwardhan
medRxiv 2021.06.12.21258345; doi: https://doi.org/10.1101/2021.06.12.21258345
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Coadministration of AYUSH 64 as an adjunct to Standard of Care in mild and moderate COVID-19: A randomised, controlled, multicentric clinical trial
Arvind Chopra, Girish Tillu, Kuldeep Chuadhary, Govind Reddy, Alok Srivastava, Muffazal Lakdawala, Dilip Gode, Himanshu Reddy, Sanjay Tamboli, Manjit Saluja, Sanjeev Sarmukkaddam, Manohar Gundeti, Ashwinikumar Raut, BCS Rao, Babita Yadav, Narayanam Srikanth, Bhushan Patwardhan
medRxiv 2021.06.12.21258345; doi: https://doi.org/10.1101/2021.06.12.21258345

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Pharmacology and Therapeutics
Subject Areas
All Articles
  • Addiction Medicine (280)
  • Allergy and Immunology (579)
  • Anesthesia (139)
  • Cardiovascular Medicine (1943)
  • Dentistry and Oral Medicine (252)
  • Dermatology (184)
  • Emergency Medicine (333)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (698)
  • Epidemiology (11098)
  • Forensic Medicine (8)
  • Gastroenterology (622)
  • Genetic and Genomic Medicine (3164)
  • Geriatric Medicine (308)
  • Health Economics (561)
  • Health Informatics (2042)
  • Health Policy (862)
  • Health Systems and Quality Improvement (782)
  • Hematology (310)
  • HIV/AIDS (682)
  • Infectious Diseases (except HIV/AIDS) (12714)
  • Intensive Care and Critical Care Medicine (707)
  • Medical Education (317)
  • Medical Ethics (92)
  • Nephrology (334)
  • Neurology (2981)
  • Nursing (164)
  • Nutrition (463)
  • Obstetrics and Gynecology (589)
  • Occupational and Environmental Health (614)
  • Oncology (1549)
  • Ophthalmology (476)
  • Orthopedics (185)
  • Otolaryngology (266)
  • Pain Medicine (202)
  • Palliative Medicine (57)
  • Pathology (402)
  • Pediatrics (912)
  • Pharmacology and Therapeutics (381)
  • Primary Care Research (355)
  • Psychiatry and Clinical Psychology (2782)
  • Public and Global Health (5588)
  • Radiology and Imaging (1092)
  • Rehabilitation Medicine and Physical Therapy (631)
  • Respiratory Medicine (759)
  • Rheumatology (338)
  • Sexual and Reproductive Health (311)
  • Sports Medicine (289)
  • Surgery (343)
  • Toxicology (48)
  • Transplantation (159)
  • Urology (132)